Observational studyPloS one2015

Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention.

Jinghan Jenny Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.